
Nicole Erin Kinsey White
Examiner (ID: 18489, Phone: (571)272-9943 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1130 |
| Issued Applications | 560 |
| Pending Applications | 136 |
| Abandoned Applications | 472 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10641406
[patent_doc_number] => 09358258
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-07
[patent_title] => 'Isolated bacteriophage having E. coli-specific bactericidal activity and antibacterial composition comprising the same'
[patent_app_type] => utility
[patent_app_number] => 14/345189
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 7247
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14345189
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/345189 | Isolated bacteriophage having E. coli-specific bactericidal activity and antibacterial composition comprising the same | Nov 13, 2012 | Issued |
Array
(
[id] => 9413044
[patent_doc_number] => 08697080
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-15
[patent_title] => 'Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments'
[patent_app_type] => utility
[patent_app_number] => 13/675422
[patent_app_country] => US
[patent_app_date] => 2012-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20905
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13675422
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/675422 | Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments | Nov 12, 2012 | Issued |
Array
(
[id] => 8814198
[patent_doc_number] => 20130115243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'IMMUNOGENIC FORMULATIONS AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/672190
[patent_app_country] => US
[patent_app_date] => 2012-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 14099
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13672190
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/672190 | Virally infected hematopoietic cells and uses thereof | Nov 7, 2012 | Issued |
Array
(
[id] => 9805684
[patent_doc_number] => 20150017629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'DEVICE AND METHOD FOR BACTERIAL CULTURE AND ASSAY'
[patent_app_type] => utility
[patent_app_number] => 14/354539
[patent_app_country] => US
[patent_app_date] => 2012-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 14852
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354539
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/354539 | Device and method for bacterial culture and assay | Oct 28, 2012 | Issued |
Array
(
[id] => 9785671
[patent_doc_number] => 20140302491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'Ex Vivo Culture, Proliferation and Expansion of Primary Tissue Organoids'
[patent_app_type] => utility
[patent_app_number] => 14/354390
[patent_app_country] => US
[patent_app_date] => 2012-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 19359
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354390
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/354390 | Ex Vivo Culture, Proliferation and Expansion of Primary Tissue Organoids | Oct 28, 2012 | Abandoned |
Array
(
[id] => 11880771
[patent_doc_number] => 09751931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-05
[patent_title] => 'Hepatitis C virus neutralizing antibodies and methods'
[patent_app_type] => utility
[patent_app_number] => 14/437593
[patent_app_country] => US
[patent_app_date] => 2012-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 20823
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437593
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/437593 | Hepatitis C virus neutralizing antibodies and methods | Oct 25, 2012 | Issued |
Array
(
[id] => 10967461
[patent_doc_number] => 20140370495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'RECOMBINANT MYCOBACTERIOPHAGES FOR DELIVERY OF NUCLEIC ACIDS OF INTEREST INTO MYCOBACTERIA'
[patent_app_type] => utility
[patent_app_number] => 14/352761
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11993
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352761
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/352761 | Recombinant mycobacteriophages for delivery of nucleic acids of interest into mycobacteria | Oct 18, 2012 | Issued |
Array
(
[id] => 9685340
[patent_doc_number] => 20140242104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'SELF-ASSEMBLING PEPTIDE NANOPARTICLES AS VACCINES AGAINST INFECTION WITH NOROVIRUS'
[patent_app_type] => utility
[patent_app_number] => 14/350426
[patent_app_country] => US
[patent_app_date] => 2012-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8608
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350426
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350426 | SELF-ASSEMBLING PEPTIDE NANOPARTICLES AS VACCINES AGAINST INFECTION WITH NOROVIRUS | Oct 4, 2012 | Abandoned |
Array
(
[id] => 11211990
[patent_doc_number] => 09441019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-13
[patent_title] => 'Influenza hemagglutinin protein-based vaccines'
[patent_app_type] => utility
[patent_app_number] => 14/346849
[patent_app_country] => US
[patent_app_date] => 2012-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 87
[patent_figures_cnt] => 85
[patent_no_of_words] => 40215
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346849
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/346849 | Influenza hemagglutinin protein-based vaccines | Sep 23, 2012 | Issued |
Array
(
[id] => 9222430
[patent_doc_number] => 20140017205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'BACTERIOPHAGE AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/621688
[patent_app_country] => US
[patent_app_date] => 2012-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12720
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13621688
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/621688 | Bacteriophage and antibacterial composition comprising the same | Sep 16, 2012 | Issued |
Array
(
[id] => 8637131
[patent_doc_number] => 20130028935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'COMPOSITION CONTAINING HCMV PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 13/612959
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12970
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13612959
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/612959 | COMPOSITION CONTAINING HCMV PARTICLES | Sep 12, 2012 | Abandoned |
Array
(
[id] => 8670692
[patent_doc_number] => 20130045230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'COMPOSITION CONTAINING HCMV PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 13/613208
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12971
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13613208
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/613208 | COMPOSITION CONTAINING HCMV PARTICLES | Sep 12, 2012 | Abandoned |
Array
(
[id] => 8708020
[patent_doc_number] => 20130065309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'Preparation of Negative-Stranded RNA Viruses By Electroporation'
[patent_app_type] => utility
[patent_app_number] => 13/613286
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16474
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13613286
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/613286 | Preparation of Negative-Stranded RNA Viruses By Electroporation | Sep 12, 2012 | Abandoned |
Array
(
[id] => 8720207
[patent_doc_number] => 20130071424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'PEPTIDES MIMICKING HIV-1 VIRAL EPITOPES IN THE V2 LOOP FOR THE GP120 SURFACE ENVELOPE GLYCOPROTEIN'
[patent_app_type] => utility
[patent_app_number] => 13/612300
[patent_app_country] => US
[patent_app_date] => 2012-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15443
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13612300
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/612300 | Peptides mimicking HIV-1 viral epitopes in the V2 loop for the GP120 surface envelope glycoprotein | Sep 11, 2012 | Issued |
Array
(
[id] => 9389324
[patent_doc_number] => 08685923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-01
[patent_title] => 'Fibrillar albumin for use in inhibiting cancer growth'
[patent_app_type] => utility
[patent_app_number] => 13/572652
[patent_app_country] => US
[patent_app_date] => 2012-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11613
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13572652
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/572652 | Fibrillar albumin for use in inhibiting cancer growth | Aug 11, 2012 | Issued |
Array
(
[id] => 9642548
[patent_doc_number] => 20140220659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'THE METHOD OF OBTAINING A STRAIN OF BACTERIOFAGE, SPECIFIC STRAINS OF BACTERIOPHAGE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/240195
[patent_app_country] => US
[patent_app_date] => 2012-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7443
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240195
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/240195 | Bacteriophage with activity against pathogenic strains of Salmonella | Aug 8, 2012 | Issued |
Array
(
[id] => 8503218
[patent_doc_number] => 20120302627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'METHOD OF USING ADENOVIRAL VECTORS TO INDUCE AN IMMUNE RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 13/568239
[patent_app_country] => US
[patent_app_date] => 2012-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25071
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13568239
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/568239 | METHOD OF USING ADENOVIRAL VECTORS TO INDUCE AN IMMUNE RESPONSE | Aug 6, 2012 | Abandoned |
Array
(
[id] => 8744620
[patent_doc_number] => 20130084337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'PURE FILAMENTOUS BACTERIOPHAGE AND METHODS OF PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/566274
[patent_app_country] => US
[patent_app_date] => 2012-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 29191
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13566274
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/566274 | PURE FILAMENTOUS BACTERIOPHAGE AND METHODS OF PRODUCING SAME | Aug 2, 2012 | Abandoned |
Array
(
[id] => 10398218
[patent_doc_number] => 20150283226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'COMPOSITIONS AND METHODS OF MODULATING AN IMMUNE RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 14/373841
[patent_app_country] => US
[patent_app_date] => 2012-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11985
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14373841
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/373841 | COMPOSITIONS AND METHODS OF MODULATING AN IMMUNE RESPONSE | Jul 30, 2012 | Abandoned |
Array
(
[id] => 9642549
[patent_doc_number] => 20140220660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'PROCESS FOR THE PRODUCTION OF FILAMENTOUS BACTERIOPHAGE'
[patent_app_type] => utility
[patent_app_number] => 14/234500
[patent_app_country] => US
[patent_app_date] => 2012-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 20473
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14234500
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/234500 | PROCESS FOR THE PRODUCTION OF FILAMENTOUS BACTERIOPHAGE | Jul 26, 2012 | Abandoned |